Myopia Profile

Eyerising Myopia Management Device

The Eyerising Myopia Management Device delivers Repeated Low-Level Red-Light (RLRL) therapy to the ocular fundus through semi-conductor laser diodes emitting 650nm visible red light. The Eyerising device has been demonstrated to increase choroidal blood flow and induce choroidal thickening, potentially addressing the scleral hypoxia implicated in myopia progression. It is backed by over 40 clinical studies, including 2-year clinical trial results showing myopia control efficacy.

Visit the Eyerising Myopia Management Device website.

Instrument
Eyerising International
Eyerising Myopia Management Device
Myopia control device that delivers repeated low-level red-light (RLRL) to the ocular fundus.
Securely shares patient compliance data with practitioners to monitor efficacy and safe use
 Silver Sponsor Light therapies

Articles on Eyerising Myopia Management Device.

Real-world cases with red light therapyFour real-world cases show how repeated low-level red-light (RLRL) therapy can be a powerful tool for myopia management.Read Full Article Three key myopia questions for 2026 Atropine 0.01% monotherapy, second generation spectacle lenses and light therapy combo treatments - much to learn!Read Full Article Repeated low-level red light and ortho-k combined: first European dataCombining RLRL with ortho-k slowed eye growth by 0.23 mm in Spanish children, with 80% showing axial shortening after 12 months.Read Full Article
Real-world cases with red light therapyFour real-world cases show how repeated low-level red-light (RLRL) therapy can be a powerful tool for myopia management.Read Full Article

Eyerising International resources

Eyerising.png

Eyerising International and Myopia Profile Interview Series: Highlights

Eyerising International recently undertook a series of video interviews where global experts spoke to Dr Kate Gifford of Myopia Profile about their clinical experiences, observations and work with the Eyerising Myopia Management Device.

To watch the interviews in full, please visit
https://www.eyerisinginternational.com/the-device/